Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Algorithmic Trading
View:
Post by Ingiboy on Dec 03, 2020 1:47pm

Algorithmic Trading

The share price has no chance of rising today with this algorithmic trading activity:

Recent Trades - Last 10 of 26
Time ET Ex Price Change Volume Buyer Seller Markers
12:59:30 V 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 V 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 V 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 U 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 U 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 V 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 V 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 U 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 V 0.21 -0.01 500 2 RBC 80 National Bank K
12:59:29 U 0.21 -0.01 500 2 RBC 80 National Bank K
 

Also I am growing tired of the  meaninglessTitter teasers.  

"Based on how little 'red text' we're seeing in the latest versions of the draft definitive agreements with MainPointe Pharma, we're bullish on our chances this deal closes with plenty of days left in 2020. #holidaycheer."

Stop the BS and lets get some real information.  If your going to tweet something make it meaningful.


 

 

 

Comment by MetzGER on Dec 03, 2020 4:38pm
Feel free to go to the zoom conference next weeek and ask your questions. i‘m glad that Replicel is posting on twitter and I am aware that they can’t give breaking news every week. It is better now then in the last months when we were hearing NOTHING. 
Comment by Genie29j on Dec 03, 2020 8:00pm
I second that. I love the Twitter activity.  Who in the right mind doesn't want to be informed with what's going on with a company they invested in? Definitely Not me! 
Comment by Ingiboy on Dec 03, 2020 10:45pm
Guys you have missed my point.  What do you know today that you didn't know a few days ago before the Tweets? Give us some real information not some cryptic twitter message saying the deal should be done before the end of the year.  I would have assumed that anyway.  And by the way I respond to NR's not Tweets.  Get the deal done and give us the game plan.  That ...more  
Comment by Genie29j on Dec 04, 2020 9:29am
To me that is real information. When I think back to YOFOTO, it was significantly delayed, but we had no idea...  this time, the redlining of the agreement is going quicker than expected, which to me means they will get $$ sooner than expected, which will help expedite the device. For me, Sometimes it's not just about the  black & white headlines, but in this case you need to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities